Answer
Eribulin mesylate inhibits the growth phase of microtubules without affecting their shortening phase.
Sources for this answer
- Eribulin Eisai 0.44 mg/ml solution for injectionEisai Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 26Document updated
Sources checked